The Neisseria meningitidis lpxL1 mutant induces less tissue factor expression and activity in primary human monocytes

Marit Hellum1,2, Anne-Marie S Trøseid2, Jens P Berg1,2

  • 11 Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Innate Immunity
|December 28, 2016
PubMed

Insights

A mutated Neisseria meningitidis (N. meningitidis) with fewer acyl chains causes milder disease. This lpxL1 mutant is a weaker inducer of tissue factor (TF), reducing inflammation and coagulopathy.

Area of Science:

  • Microbiology
  • Immunology
  • Hematology

Background:

  • Neisseria meningitidis (N. meningitidis) can cause severe sepsis and meningitis.
  • Lipid A's acyl chain number influences N. meningitidis pathogenicity.
  • Tissue factor (TF) initiates coagulation and is crucial in sepsis-induced coagulopathy.

Purpose of the Study:

  • To investigate the effect of a mutated lpxL1 gene in N. meningitidis on tissue factor (TF) expression and TF-dependent thrombin generation.
  • To compare the inflammatory and coagulopathic potential of lpxL1 mutant N. meningitidis with wild-type (wt) strains.

Main Methods:

  • Human primary monocytes and whole blood were incubated with either lpxL1 mutant or wt N. meningitidis (H44/76).
  • Monocyte and microvesicle (MV)-associated TF expression was measured.
  • TF-dependent thrombin generation was assessed.

Main Results:

  • The lpxL1 mutant was a weaker inducer of both monocyte and MV-associated TF compared to the wt strain.
  • This reduced TF induction was observed in both purified monocytes and whole blood.
  • Lower levels of circulating TF were associated with the lpxL1 mutant infection.

Conclusions:

  • The lpxL1 mutation in N. meningitidis leads to reduced TF expression and activity.
  • This diminished TF response likely contributes to the observed milder meningococcal disease, characterized by less systemic inflammation and coagulopathy.
  • Targeting lipid A modification could be a strategy to attenuate meningococcal virulence.